Prevalence and clinical characteristics of persistent airflow limitation in a cohort of adults with asthma and/or chronic obstructive pulmonary disease

Authors

Institutions

Publication Details

Journal
Annals of the American Thoracic Society
Published
2025-09-17
DOI
https://doi.org/10.1513/annalsats.202412-1273oc
Citations
2
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
3.04
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence and clinical characteristics of persistent airflow limitation in a cohort of adults with asthma and/or chronic obstructive pulmonary disease

Maarten van den Berge, Ricardo del Olmo, Hiroshi Inoue, Helen Kathryn Reddel et al.
2 citations
Annals of the American Thoracic Society
Chronic Obstructive Pulmonary Disease (COPD) Research
3.04
article

Prevalence and clinical characteristics of persistent airflow limitation in a cohort of adults with asthma and/or chronic obstructive pulmonary disease

Maarten van den Berge, Ricardo del Olmo, Hiroshi Inoue, Helen Kathryn Reddel, Hana Müllerová, Eleni Rapsomaniki, Peter Calverley, Alberto Papi, Christer Janson, David Price, Alvar G.N. Agustí, Richard Beasley, Anastasios Mangelis, Bradley E. Chipps, Rod Hughes
article en
2 citations

Abstract

No abstract available for this paper.
Annals of the American Thoracic SocietyVol. 23(2)
AstraZeneca (United Kingdom) (GB), Kagoshima University (JP), LifeArc (GB), Uppsala University (SE), University Medical Center Groningen (NL), University of Liverpool (GB), University of Groningen (NL), GlaxoSmithKline (United Kingdom) (GB), University of Aberdeen (GB), University of Ferrara (IT), Police Service of Northern Ireland (GB), Woolcock Institute of Medical Research (AU), Capital Allergy and Respiratory Disease Center (US), AstraZeneca (South Korea) (KR), Hospital Fernández (AR), AstraZeneca (France) (FR), AstraZeneca (Netherlands) (NL), AstraZeneca (Singapore) (SG), Hospital Clínic de Barcelona (ES), Observational & Pragmatic Research Institute (SG), AstraZeneca (Switzerland) (CH), Medical Research Institute of New Zealand (NZ), AstraZeneca (Poland) (PL), AstraZeneca (Italy) (IT), Hospital Maria Pia (PT), Universitat de Barcelona (ES), Macquarie University (AU)
Openalex Percentile: Top 8%
Chronic Obstructive Pulmonary Disease (COPD) Research
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.